Ambros Therapeutics’ Path for Pain Drug Goes Through Reverse Merger With WerewolfNews DeskAugust 21, 20260 Some types of pain don’t respond to currently available medicines. Ambros Therapeutics’ in-licensed drug candidate is in pivotal testing for…